Daniel Amos

Daniel P. Amos is chairman and chief executive officer of Aflac Incorporated. Aflac’s own leadership page describes him as the longest-serving CEO in the Fortune 250, having led the company as CEO for more than 36 years. He joined Aflac in his teens for summer work and, after earning a bachelor’s degree in insurance and risk management from the University of Georgia, joined the company’s sales area on commission.

Amos rose through Aflac’s sales organization before moving into executive management. Aflac says his Alabama/West Florida sales territory was the company’s number-one-producing area in 1981 and 1982; he was named president of Aflac in 1983, chief operating officer in 1987, chief executive officer in 1990, and chairman of the board in 2001.

A major part of Amos’s public record is brand building and international execution rather than venture investing. In 2000, he launched the Aflac Duck advertising campaign, which Aflac credits with turning the company from a successful supplemental insurer into a top international brand. Under his tenure, Aflac has remained heavily oriented around Japan and the United States; the company says Aflac is a leading provider of medical and cancer insurance in Japan and the number-one provider of supplemental health insurance products in the U.S.

Amos is also closely associated with Aflac’s philanthropy in pediatric cancer and sickle cell disease. Aflac says Dan and Kathelen Amos helped spearhead the company’s support for children diagnosed with cancer and their families, including support for the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and the My Special Aflac Duck social robot program.

• No verified public source found that presents Amos as an active angel investor with a published personal seed-stage thesis, check size, or startup portfolio. The stub claim that he is an “Angel Investor” could not be corroborated from primary sources reviewed.
• Amos’s public operating focus is insurance, especially supplemental health insurance, cancer/medical insurance, and the U.S./Japan distribution model.
• Aflac’s relevant strategic lens is financial protection for policyholders: the company describes its role as paying cash fast when policyholders get sick or injured so they can “focus on recovery, not financial stress.”
• Amos emphasizes predictability, consistency, and delegated execution. In a 2026 Financial Times interview, he said, “One thing I have worked at is to be consistent, readable, and predictable,” and added that Aflac does not try to run Japan from Columbus but sets guardrails and lets local teams operate within their culture.
• For any founder treating Amos/Aflac as a strategic counterparty, the fit appears strongest where a company can improve insurance distribution, policyholder experience, claims support, health-related customer engagement, or Aflac’s Japan/U.S. operating priorities.